Pacira Pharmaceuticals buy Jefferies Financial Group Inc.
Start price
24.09.24
/
50%
€12.60
Target price
24.09.25
€16.13
Performance (%)
73.02%
End price
25.09.25
€21.80
Summary
This prediction ended on 25.09.25 with a price of €21.80. The BUY prediction by Jefferies_Financial_ for Pacira Pharmaceuticals saw massive gains of 73.02%. Jefferies_Financial_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Pacira Pharmaceuticals | 3.571% | 3.571% | 25.405% |
| iShares Core DAX® | 1,01 % | 2,70 % | 4,36 % |
| iShares Nasdaq 100 | -6,47 % | -8,77 % | 18,00 % |
| iShares Nikkei 225® | -6,52 % | -12,58 % | 40,91 % |
| iShares S&P 500 | -2,72 % | -1,75 % | 16,97 % |
Comments by Jefferies_Financial_ for this prediction
In the thread Pacira Pharmaceuticals diskutieren
Pacira BioSciences, Inc. (NASDAQ: PCRX) had its price target raised by analysts at Jefferies Financial Group Inc. from $15.00 to $18.00. They now have a "buy" rating on the stock.
Ratings data for PCRX provided by MarketBeat
In the thread Trading Pacira Pharmaceuticals
Die von Jefferies_Financial_ gewählte maximale Laufzeit wurde überschritten